Pulse Biosciences, Inc. PLSE Operating lease right-of-use asset amortization
Operating lease right-of-use asset amortization at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulse Biosciences, Inc.'s operating lease right-of-use asset amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulse Biosciences, Inc.'s operating lease right-of-use asset amortization?
- Pulse Biosciences, Inc. (PLSE) reported operating lease right-of-use asset amortization of $308K in Q1 2026.
- How has Pulse Biosciences, Inc.'s operating lease right-of-use asset amortization changed year-over-year?
- Pulse Biosciences, Inc.'s operating lease right-of-use asset amortization increased by 12.4% year-over-year, from $274K to $308K.